English | Español
Patient Daily | Mar 11, 2026

Roche invests $480 million to expand clinical trial capacity in South Korea
Patient Daily | Mar 11, 2026

FDA partially pauses PepGen's phase 2 trial for myotonic dystrophy
Patient Daily | Mar 11, 2026

FDA official seeks hire amid controversy over antidepressant warnings
Patient Daily | Mar 11, 2026

Alnylam partners with Tenaya Therapeutics on genetic heart disease research
Patient Daily | Mar 11, 2026

Analysts say psychedelics unlikely to dominate depression treatment market
Patient Daily | Mar 11, 2026

UniQure weighs next steps after FDA requests new phase 3 trial for Huntington's gene therapy
Patient Daily | Mar 11, 2026

Targeted mRNA restores fertility in genetically infertile male mice
Patient Daily | Mar 11, 2026

Study links impaired tanycyte function to tau buildup in Alzheimer’s disease

Trending
+ Regulatory
Patient Daily | May 18, 2026

PhRMA Deputy VP Nyman on 340B: 'It’s time to ensure 340B actually helps patients'
+ Community
Patient Daily | May 18, 2026

Alliance to Save America’s 340B Program Executive Director Johnson on 340B: 'Above all, 340B must serve patients'
+ Pharmaceuticals
Patient Daily | May 18, 2026

PhRMA CEO Stephen Ubl on 340B program: 'Patients are not benefiting'
+ Regulatory
Patient Daily | May 21, 2026

National Consumers League CEO Greenberg: '340B drug discounts are fattening the coffers of large hospitals'